vs
Side-by-side financial comparison of BRIGHT HORIZONS FAMILY SOLUTIONS INC. (BFAM) and PERRIGO Co plc (PRGO). Click either name above to swap in a different company.
PERRIGO Co plc is the larger business by last-quarter revenue ($1.1B vs $733.7M, roughly 1.5× BRIGHT HORIZONS FAMILY SOLUTIONS INC.). On growth, BRIGHT HORIZONS FAMILY SOLUTIONS INC. posted the faster year-over-year revenue change (8.8% vs -2.5%). BRIGHT HORIZONS FAMILY SOLUTIONS INC. produced more free cash flow last quarter ($258.5M vs $148.6M). Over the past eight quarters, BRIGHT HORIZONS FAMILY SOLUTIONS INC.'s revenue compounded faster (8.5% CAGR vs 1.3%).
Bright Horizons Family Solutions Inc. is a United States–based child-care provider and is the largest provider of employer-sponsored child care. It also provides back-up child care and elder care, tuition program management, education advising, and student loan repayment programs. It is headquartered in Newton, Massachusetts.
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters ...
BFAM vs PRGO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $733.7M | $1.1B |
| Net Profit | — | $-1.4B |
| Gross Margin | 19.3% | 32.6% |
| Operating Margin | 6.2% | -116.0% |
| Net Margin | — | -127.8% |
| Revenue YoY | 8.8% | -2.5% |
| Net Profit YoY | — | -3093.9% |
| EPS (diluted) | $0.38 | $-10.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $733.7M | $1.1B | ||
| Q3 25 | $802.8M | $1.0B | ||
| Q2 25 | $731.6M | $1.1B | ||
| Q1 25 | $665.5M | $1.0B | ||
| Q4 24 | $674.1M | $1.1B | ||
| Q3 24 | $719.1M | $1.1B | ||
| Q2 24 | $670.1M | $1.1B | ||
| Q1 24 | $622.7M | $1.1B |
| Q4 25 | — | $-1.4B | ||
| Q3 25 | $78.6M | $7.5M | ||
| Q2 25 | $54.8M | $-8.4M | ||
| Q1 25 | $38.0M | $-6.4M | ||
| Q4 24 | — | $-44.4M | ||
| Q3 24 | $54.9M | $-21.0M | ||
| Q2 24 | $39.2M | $-108.4M | ||
| Q1 24 | $17.0M | $2.0M |
| Q4 25 | 19.3% | 32.6% | ||
| Q3 25 | 27.0% | 36.1% | ||
| Q2 25 | 25.0% | 34.4% | ||
| Q1 25 | 23.4% | 37.6% | ||
| Q4 24 | 20.8% | 33.9% | ||
| Q3 24 | 25.2% | 37.2% | ||
| Q2 24 | 24.2% | 37.0% | ||
| Q1 24 | 21.7% | 33.1% |
| Q4 25 | 6.2% | -116.0% | ||
| Q3 25 | 15.1% | 7.0% | ||
| Q2 25 | 11.8% | 4.3% | ||
| Q1 25 | 9.4% | 4.5% | ||
| Q4 24 | 7.2% | 10.0% | ||
| Q3 24 | 12.4% | 7.4% | ||
| Q2 24 | 10.3% | -2.5% | ||
| Q1 24 | 6.4% | -5.1% |
| Q4 25 | — | -127.8% | ||
| Q3 25 | 9.8% | 0.7% | ||
| Q2 25 | 7.5% | -0.8% | ||
| Q1 25 | 5.7% | -0.6% | ||
| Q4 24 | — | -3.9% | ||
| Q3 24 | 7.6% | -1.9% | ||
| Q2 24 | 5.8% | -10.2% | ||
| Q1 24 | 2.7% | 0.2% |
| Q4 25 | $0.38 | $-10.23 | ||
| Q3 25 | $1.37 | $0.05 | ||
| Q2 25 | $0.95 | $-0.06 | ||
| Q1 25 | $0.66 | $-0.05 | ||
| Q4 24 | $0.50 | $-0.32 | ||
| Q3 24 | $0.94 | $-0.15 | ||
| Q2 24 | $0.67 | $-0.79 | ||
| Q1 24 | $0.29 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $140.1M | — |
| Total DebtLower is stronger | $747.6M | — |
| Stockholders' EquityBook value | $1.3B | $2.9B |
| Total Assets | $3.9B | $8.5B |
| Debt / EquityLower = less leverage | 0.56× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $140.1M | — | ||
| Q3 25 | $116.6M | $432.1M | ||
| Q2 25 | $179.2M | $454.2M | ||
| Q1 25 | $112.0M | $409.9M | ||
| Q4 24 | $110.3M | $558.8M | ||
| Q3 24 | $109.9M | $1.5B | ||
| Q2 24 | $140.2M | $542.8M | ||
| Q1 24 | $63.7M | $658.5M |
| Q4 25 | $747.6M | — | ||
| Q3 25 | $747.5M | — | ||
| Q2 25 | $797.0M | — | ||
| Q1 25 | $872.7M | — | ||
| Q4 24 | $918.4M | — | ||
| Q3 24 | $925.7M | — | ||
| Q2 24 | $931.9M | — | ||
| Q1 24 | $938.1M | — |
| Q4 25 | $1.3B | $2.9B | ||
| Q3 25 | $1.4B | $4.4B | ||
| Q2 25 | $1.4B | $4.5B | ||
| Q1 25 | $1.3B | $4.4B | ||
| Q4 24 | $1.3B | $4.3B | ||
| Q3 24 | $1.4B | $4.6B | ||
| Q2 24 | $1.3B | $4.5B | ||
| Q1 24 | $1.2B | $4.7B |
| Q4 25 | $3.9B | $8.5B | ||
| Q3 25 | $3.9B | $10.1B | ||
| Q2 25 | $3.9B | $10.1B | ||
| Q1 25 | $3.8B | $9.8B | ||
| Q4 24 | $3.9B | $9.6B | ||
| Q3 24 | $3.9B | $11.2B | ||
| Q2 24 | $3.8B | $10.4B | ||
| Q1 24 | $3.8B | $10.6B |
| Q4 25 | 0.56× | — | ||
| Q3 25 | 0.52× | — | ||
| Q2 25 | 0.57× | — | ||
| Q1 25 | 0.66× | — | ||
| Q4 24 | 0.72× | — | ||
| Q3 24 | 0.66× | — | ||
| Q2 24 | 0.73× | — | ||
| Q1 24 | 0.76× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $350.7M | $175.4M |
| Free Cash FlowOCF − Capex | $258.5M | $148.6M |
| FCF MarginFCF / Revenue | 35.2% | 13.4% |
| Capex IntensityCapex / Revenue | 12.6% | 2.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $402.4M | $145.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $350.7M | $175.4M | ||
| Q3 25 | $-17.6M | $51.7M | ||
| Q2 25 | $134.2M | $75.9M | ||
| Q1 25 | $86.2M | $-64.5M | ||
| Q4 24 | $337.5M | $312.6M | ||
| Q3 24 | $-8.9M | $42.2M | ||
| Q2 24 | $109.4M | $9.5M | ||
| Q1 24 | $116.3M | $-1.4M |
| Q4 25 | $258.5M | $148.6M | ||
| Q3 25 | $-42.4M | $29.8M | ||
| Q2 25 | $115.4M | $56.7M | ||
| Q1 25 | $70.9M | $-90.0M | ||
| Q4 24 | $240.2M | $274.9M | ||
| Q3 24 | $-32.2M | $15.1M | ||
| Q2 24 | $86.8M | $-18.9M | ||
| Q1 24 | $96.9M | $-26.5M |
| Q4 25 | 35.2% | 13.4% | ||
| Q3 25 | -5.3% | 2.9% | ||
| Q2 25 | 15.8% | 5.4% | ||
| Q1 25 | 10.7% | -8.6% | ||
| Q4 24 | 35.6% | 24.2% | ||
| Q3 24 | -4.5% | 1.4% | ||
| Q2 24 | 13.0% | -1.8% | ||
| Q1 24 | 15.6% | -2.4% |
| Q4 25 | 12.6% | 2.4% | ||
| Q3 25 | 3.1% | 2.1% | ||
| Q2 25 | 2.6% | 1.8% | ||
| Q1 25 | 2.3% | 2.4% | ||
| Q4 24 | 14.4% | 3.3% | ||
| Q3 24 | 3.2% | 2.5% | ||
| Q2 24 | 3.4% | 2.7% | ||
| Q1 24 | 3.1% | 2.3% |
| Q4 25 | — | — | ||
| Q3 25 | -0.22× | 6.89× | ||
| Q2 25 | 2.45× | — | ||
| Q1 25 | 2.26× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -0.16× | — | ||
| Q2 24 | 2.79× | — | ||
| Q1 24 | 6.85× | -0.70× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BFAM
Segment breakdown not available.
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
